Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 274 papers

Prognostic role of liver biopsy in patients with severe indeterminate acute hepatitis

Lin S, Araujo C, Hall A, Kumar R, Phillips A, Hassan M, Engelmann C, Quaglia A, Jalan R.

Clin Gastroenterol Hepatol 2022, 20(5): 1130–1141

DOI: 10.1016/j.cgh.2021.08.008

Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis

Prado V, Hernández-Tejero M, Mücke MM, Marco F, Gu W, Amoros A, Toapanta D, Reverter E, Peña-Ramirez C, Altenpeter L, Bassegoda O, Mezzano G, Aziz F, Juanola A, Rodríguez-Tajes S, Chamorro V, López D, Reyes M, Hogardt M, Kempf VAJ, Ferstl PG, Zeuzem S, Martínez JA, Vila J, Arroyo V, Trebicka J, Fernandez J.

J Hepatol 2022, 76(5): 1079-1089

DOI: 10.1016/j.jhep.2021.12.042

Role of albumin in the treatment of decompensated liver cirrhosis

Trebicka J.

Curr Opin Gastroenterol 2022, 38(3): 200–205

DOI: 10.1097/MOG.0000000000000838

Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections

Bastida C, Hernández-Tejero M, Cariqueo M, Aziz F, Fortuna V, Sanz M, Brunet M, Fernández J, Soy D.

J Antimicrob Chemother 2022, 77(5): 1365–1371

DOI: 10.1093/jac/dkac036

Combination of fat-free muscle index and total spontaneous portosystemic shunt area identifies high-risk cirrhosis patients

Faron A, Abu-Omar J, Chang J, Böhling N, Sprinkart AM, Attenberger U, Rockstroh JK, Luu AM, Jansen C, Strassburg CP, Trebicka J, Luetkens J, Praktiknjo M.

Front Med (Lausanne) 2022, 9: 831005

DOI: 10.3389/fmed.2022.831005

Presence of multilobular necrosis on liver biopsy identifies corticosteroid responsiveness in acute indeterminate hepatitis

Lin S, Araujo C, Hall A, Kumar R, Phillips A, Hassan M, Engelmann C, Quaglia A, Jalan R.

Liver Int 2022, 42(4): 853–863

DOI: 10.1111/liv.15144

Reduced plasma extracellular vesicle CD5L content in patients with acute-on-chronic liver failure: Interplay with specialized pro-resolving lipid mediators

Sánchez-Rodríguez MB, Téllez É, Casulleras M, Borràs FE, Arroyo V, Clària J, Sarrias MR.

Front Immunol 2022, 13: 842996

DOI: 10.3389/fimmu.2022.842996

Cranial stent position is independently associated with the development of TIPS dysfunction

Meyer C, Paar Pérez AM, Chang J, Sprinkart AM, Böhling N, Luu AM, Kütting D, Jansen C, Luetkens J, Bischoff LM, Attenberger U, Strassburg CP, Trebicka J, Wolter K, Praktiknjo M.

Sci Rep 2022, 12(1): 3559

DOI: 10.1038/s41598-022-07595-5

Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS

Li M, Li K, Tang S, Lv Y, Wang Q, Wang Z, Luo B, Niu J, Zhu Y, Guo W, Bai W, Wang E, Xia D, Wang Z, Li X, Yuan J, Yin Z, Trebicka J, Han G.

JHEP Rep 2022, 4(5): 100448

DOI: 10.1016/j.jhepr.2022.100448

Cirrhosis-associated immune dysfunction

Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, Álvarez-Mon M.

Nat Rev Gastroenterol Hepatol 2022, 19(2): 112–134

DOI: 10.1038/s41575-021-00520-7

Registered office

European Foundation for the Study of
Chronic Liver Failure
Avinguda Diagonal 477, 11th floor
08036 Barcelona, Spain

Legal

Contact us

Tel: +34 93 227 14 00
Email: Send us an email

© European Foundation for the Study of Chronic Liver Failure 2024